Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)
Others
Ratios

Benitec Biopharma (BNTC) Shares Outstanding (2019 - 2025)

Benitec Biopharma's Shares Outstanding history spans 7 years, with the latest figure at $25.5 million for Q1 2025.

  • For Q1 2025, Shares Outstanding rose 837.55% year-over-year to $25.5 million; the TTM value through Mar 2025 reached $25.5 million, up 837.55%, while the annual FY2024 figure was $10.1 million, 503.42% up from the prior year.
  • Shares Outstanding for Q1 2025 was $25.5 million at Benitec Biopharma, up from $23.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $25.5 million in Q1 2025 and bottomed at $480688.0 in Q2 2021.
  • The 5-year median for Shares Outstanding is $2.7 million (2024), against an average of $7.2 million.
  • The largest annual shift saw Shares Outstanding tumbled 90.26% in 2024 before it soared 837.55% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $8.2 million in 2021, then crashed by 79.86% to $1.6 million in 2022, then skyrocketed by 57.5% to $2.6 million in 2023, then surged by 804.61% to $23.5 million in 2024, then increased by 8.93% to $25.5 million in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Shares Outstanding are $25.5 million (Q1 2025), $23.5 million (Q4 2024), and $17.9 million (Q3 2024).